[The value of leukotriene receptor antagonists in the therapy of bronchial asthma one year following the introduction of Montelukast. Symposium at Munich, 6 March 1999].
D000085:Acetates / Q000494:pharmacology / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D003521:Cyclopropanes; D006801:Humans; D020024:Leukotriene Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use*; D013440:Sulfides
D000085:Acetates; D003521:Cyclopropanes; D020024:Leukotriene Antagonists; D011804:Quinolines; D013440:Sulfides; C093875:montelukast
Welchen Stellenwert haben Leukotrien-Rezeptorantagonisten in der Therapie des Asthma bronchiale ein Jahr nach der Einführung von Montelukast. Symposium am 6. März 1999 in München.